For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250325:nRSY1186Ca&default-theme=true
RNS Number : 1186C Bridgepoint Group plc 25 March 2025
Bridgepoint Group plc
("Bridgepoint" or the "Company")
Additional Listing
Bridgepoint announces that it intends to issue 1,762,501 ordinary shares of
£0.00005 each ("New Ordinary Shares") to satisfy vesting awards under
Bridgepoint's Long Term Incentive Plan. The New Ordinary Shares will rank pari
passu with existing ordinary shares in issue.
An application has been made for the admission of the New Ordinary Shares to
listing on the Official List and to trading on the LSE's main market for
listed securities.
Admission is expected to occur on 28 March 2025.
In conformity with the Financial Conduct Authority's Disclosure and
Transparency Rules, Bridgepoint announces that its total issued share capital
following the issue of the New Ordinary Shares will comprise:
• 825,563,402 ordinary shares of £0.00005 each with voting rights; and
• 500 deferred shares of £81 each, 1 deferred share of £1, and 1 deferred
share of £0.01, each with no voting rights.
Bridgepoint holds no shares in treasury. Following the issue of the New
Ordinary Shares the total number of voting rights in the Company will
therefore be 825,563,402, and this figure may be used by shareholders at such
time as the denominator for the calculation by which they will determine if
they are required to notify their interest in, or a change to their interest
in, Bridgepoint under the Disclosure Guidance and Transparency Rules.
ENQUIRIES
Bridgepoint
Analysts and investors Media
Adam Key Christian Jones
Adam.Key@bridgepointgroup.com (mailto:Adam.Key@bridgepointgroup.com) Christian.Jones@bridgepointgroup.com
+44 7833 748010 (mailto:Christian.Jones@bridgepointgroup.com)
+44 20 7034 3500
FGS Global (Public Relations Adviser to Bridgepoint)
James Murgatroyd / +44 20 7251 3801 / +44 7768 254 911
Anjali Unnikrishnan / +44 20 7251 3801 / +44 7826 534 233
Bridgepoint-LON@fgsglobal.com (mailto:Bridgepoint-LON@fgsglobal.com)
Issued by Bridgepoint Group plc
LEI: 213800KFNMVI8PDZX472
Registered in England and Wales no. 11443992
Registered office: 5 Marble Arch, London, W1H 7EJ
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END ALSQELFLEXLLBBF